Valuation: Asahi Kasei Corporation

Market Cap 2,210B 14.04B 12.35B 11.68B 10.59B 19.89B 1,348B 20B 140B 53.99B 688B 52.71B 51.57B P/E 2027 *
13.1x
P/E 2028 * 12x
Enterprise Value 2,858B 18.16B 15.97B 15.1B 13.7B 25.72B 1,743B 25.87B 181B 69.82B 889B 68.16B 66.69B EV / Sales 2027 *
0.87x
EV / Sales 2028 * 0.83x
Free-Float
96.37%
Yield 2027 *
2.75%
Yield 2028 * 3%
09-15 Asahi Kasei Bioprocess Unveils Vantij Su-Vfc Benchtop for Automated Single-Use Virus Filtration CI
09-14 Asahi Kasei Unit Starts Phase Two Study of Antifungal Cresemba for Pediatric Patients in Japan MT
08-26 Asahi Kasei Unveils New Wet-Process Separator Coating Line in North Carolina, Advancing the Company?s 40-Year North American Battery Separator Strategy CI
08-20 Asahi Kasei Develops Novel Lithium Pre-Doping Technology For Silicon-Rich Lithium-Ion Batteries CI
08-19 Asahi Kasei Expands Capacity For Water Electrolysis And Chlor-Alkali Equipment In Kawasaki CI
08-17 Tranche Update on Asahi Kasei Corporation's Equity Buyback Plan announced on November 5, 2025. CI
08-12 Asahi Kasei Corporation's Equity Buyback announced on November 5, 2025, has closed with 22,859,400 shares, representing 1.69% for ¥39,999.9 million. CI
08-06 Asahi Kasei Corporation and Highchem Shanghai Enter First License Agreement for Production and Sale of Acetolyte Novel Electrolyte in China CI
07-31 Asahi Kasei's Attributable Net Income Surges 173% in Fiscal Q1 MT
07-30 Asahi Kasei Corporation Provides Dividend Guidance for the End of Second Quarter of Fiscal Year Ending March 31, 2027 CI
07-30 Asahi Kasei Corporation Provides Consolidated Earnings Guidance for the Six Months and Fiscal Year Ending March 31, 2027 CI
07-30 Asahi Kasei Corporation Provides Dividend Guidance for the End of Fourth Quarter of Fiscal Year Ending March 31, 2027 CI
07-30 Asahi Kasei Corporation Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
1 day-0.24%
1 week+2.59%
Current month-0.15%
1 month-0.45%
3 months-8.50%
6 months+4.59%
Current year+18.18%
1 week 1,603
Extreme 1603
1,662
1 month 1,518
Extreme 1518
1,700
Current year 1,415
Extreme 1415
1,906
1 year 1,144.5
Extreme 1144.5
1,906
3 years 880
Extreme 880
1,906
5 years 880
Extreme 880
1,906
10 years 606.1
Extreme 606.1
1,906
Manager TitleAgeSince
Director of Finance/CFO - -
President 67 2022-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 71 2022-03-31
Director/Board Member 79 2018-05-31
Director/Board Member 67 2021-05-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%+2.59%+35.44%+67.35% 14.08B
-1.27%-0.51%+21.07%+30.04% 69.59B
-0.28%-2.10%+18.06%+17.90% 49.47B
-0.94%-4.40%+1.91%+20.26% 16.11B
-0.81%-2.35%+31.77%+19.14% 10.11B
+0.07%+0.54%+18.63%-18.58% 9.8B
+1.60%+1.92%+16.50% - 9.09B
-0.21%+3.33%+110.80%-7.45% 8.95B
-1.60%-2.77%-11.19%+10.06% 7.83B
-1.38%-0.38%+48.86%+28.51% 7.08B
Average -0.44%-0.01%+29.18%+18.58% 20.21B
Weighted average by Cap. -0.61%-0.31%+23.71%+23.19%

Financials

2027 *2028 *
Net sales 3,271B 20.78B 18.28B 17.29B 15.68B 29.44B 1,995B 29.62B 207B 79.93B 1,018B 78.03B 76.34B 3,367B 21.39B 18.81B 17.79B 16.13B 30.3B 2,053B 30.48B 213B 82.26B 1,048B 80.3B 78.56B
Net income 170B 1.08B 948M 896M 813M 1.53B 103B 1.54B 10.73B 4.15B 52.8B 4.05B 3.96B 184B 1.17B 1.03B 973M 883M 1.66B 112B 1.67B 11.65B 4.5B 57.32B 4.39B 4.3B
Net Debt 648B 4.12B 3.62B 3.42B 3.1B 5.83B 395B 5.86B 40.98B 15.83B 202B 15.45B 15.12B 572B 3.63B 3.19B 3.02B 2.74B 5.14B 349B 5.17B 36.16B 13.96B 178B 13.63B 13.34B
Logo Asahi Kasei Corporation
Asahi Kasei Corp is a Japan-based company mainly engaged in the materials business, housing business and healthcare business. The Company operates through three business segments. The Materials segment provides styrene monomer, acrylonitrile, polyethylene, automotive-related fibers, electronic materials, mixed signal large scale integrated circuits (LSI), hall elements, deep ultraviolet light-emitting diodes (LEDs), pharmaceutical and food additives and others. The Housing segment provides construction contracting, renovation and other housing-related business, as well as lightweight aerated concrete (ALC), insulation materials and others. The Healthcare segment provides medical drugs, hemodialysis and apheresis related equipment, virus removal filters, cardiopulmonary resuscitation-related products and others. The Company also provides plant engineering, environmental engineering, various research and information provision businesses, and personnel dispatch and introduction services.
Employees
47,895
Date Price Change Volume
26-09-28 JP¥1,641.50 -0.24% 4,944,200
26-09-25 JP¥1,645.50 +2.43% 5,907,600
26-09-24 JP¥1,606.50 +0.41% 4,121,500
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
1,641.50JPY
Average target price
1,965.00JPY
Spread / Average Target
+19.71%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 3407 Stock